Does the manufacturer support OEM/ODM services?

Yes, Muxiang Group offers OEM and ODM services with 20 R&D engineers and advanced production facilities.

What are the payment and shipping terms?

Payment options include LC, T/T, D/P, PayPal, etc. Lead time is one month for both peak and off-season. Ports include Shanghai and Qingdao.

Livestock Feed Additive Premix Mixed Hemiamine Hydrochloride (IV) Promote Growth

Name: Livestock Feed Additive Premix Mixed Hemiamine Hydrochloride (IV) Promote Growth
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1975412632

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$0.99-9.99

1,000 kg

Product profile

Customization

Available

Applied animal classification

Livestock

Certification

ISO

Model NO.

powder

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Type

The First Class

Transport Package

Carton; Bucket

Specification

1kg/bag; 25kg/bag

Trademark

MOOSUN

Origin

China

HS Code

3004909090

Production Capacity

50000pieces /Month

Key features

Promotes Growth & Weight Gain: Increases cattle weight by 30kg and sheep by 5kg per month compared to non-use.

Improves Feed Efficiency: Boosts feed intake by 5-10% within 3-5 days and enhances nutrient utilization.

Enhances Meat Quality: Reduces back fat, improves lean meat rate, and develops muscle shape in livestock.

Regulates Digestion: Reduces overfeeding phenomena by over 70% and improves excrement quality.

ISO Certified Manufacturer: Produced by Muxiang Group with ISO certification and 20 R&D engineers.

OEM/ODM Support: Offers custom varieties and chemical synthetic drug formulations for buyers.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤15h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.